124 completed. 124 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 124 | Completed 124 |
Follow Bioequivalence: new trials by email Literature Review of Bioequivalence trials Research Report on Bioequivalence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions Advil Tablet (Mini) (Test Product), Advil Tablet (Reference Product) - Bioequivalence, Bioavailability | Phase 1 | Completed | HALEON | 68 | 2025-12-17 | 2026-09-23 |
| Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects Levetiracetam 1500 mg, Keppra® 750 mg - Pharmacokinetic Analysis, Bioequivalence | Phase 1 | Completed | Desitin Arzneimittel GmbH | 20 | 2025-12-17 | 2026-02-06 |
| Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects Rotigotine Transdermal Delivery System (TDS) - Bioequivalence, Adhesion | Phase 1 | Completed | Amarin Technologies S.A.U. | 35 | 2025-12-04 | 2026-08-19 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions RLF-OD032 100 mg/mL oral suspension, Kuvan 100 MG Powder for Oral Solution - Bioequivalence | Phase 1 | Completed | APR Applied Pharma Research s.a. | 42 | 2025-08-20 | 2026-04-28 |
| A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants Acetylsalicylic Acid (Aspirin, BAYE004465, UI1610477), Acetylsalicylic Acid (BAYE004465, UI1615160) - Bioequivalence, Healthy Volunteers | Phase 1 | Completed | Bayer | 38 | 2025-02-26 | 2025-04-15 |
| Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 ZSP1273 tablet, zsp1273 granules - Bioequivalence | Phase 1 | Completed | Guangdong Raynovent Biotech Co., Ltd | 32 | 2023-11-23 | 2024-01-29 |
| Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. GP40221, ozempic - Pharmacokinetics, Safety Issues | Phase 1 | Completed | Geropharm | 120 | 2023-06-30 | 2024-07-11 |
| Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 60 | 2023-06-16 | 2023-11-30 |
| Bioequivalence of Amphotericin B Liposome for Injection Amphotericin B liposome for injection, AmBisome - Bioequivalence | Phase 1 | Completed | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 32 | 2023-06-02 | 2023-09-28 |
| Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h) Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h - Bioequivalence | Phase 1 | Completed | SocraTec R&D GmbH | 38 | 2023-04-17 | 2024-02-02 |
| A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial + syringe presentation - Bioequivalence | Phase 1 | Completed | argenx | 120 | 2023-03-13 | 2023-10-31 |
| Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions. Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet - Bioequivalence, Diabetes Mellitus, Type 2 | Phase 1 | Completed | Galenicum Health | 48 | 2023-01-16 | 2023-11-09 |
| Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions. Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet - Bioequivalence, Diabetes Mellitus, Type 2 | Phase 1 | Completed | Galenicum Health | 58 | 2023-01-13 | 2023-11-09 |
| Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-12-28 | 2024-01-08 |
| Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions Atorvastatin film-coated tablet 40 mg, Liprimar® film-coated tablet 40 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-11-19 | 2024-01-11 |
| Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions. Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet - Bioequivalence, Diabetes Mellitus, Type 2 | Phase 1 | Completed | Galenicum Health | 48 | 2022-11-07 | 2023-11-09 |
| Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions. Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet - Bioequivalence, Diabetes Mellitus, Type 2 | Phase 1 | Completed | Galenicum Health | 58 | 2022-10-28 | 2023-11-09 |
| Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions Ramipril tablet 10 mg, Tritace® tablet 10 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 50 | 2022-06-17 | 2023-06-29 |
| Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate), Nurofen® Forte Express, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate) - Bioequivalence, Healthy Subjects | Phase 1 | Completed | Darnitsa Pharmaceutical Company | 32 | 2022-05-17 | 2022-12-23 |
| Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions Aceclofenac film-coated tablet 100 mg, Airtal® film-coated tablet 100 mg - Bioequivalence | Phase 1 | Completed | Pharmtechnology LLC | 36 | 2022-04-15 | 2023-06-28 |
Showing 20 of 124. Sign in to see all of them.
Diabetes Mellitus, Type 2 (7) · Fasting (3) · Lecithin Cholesterol Acyltransferase Deficiency (2) · COVID-19 (1) · Graves Ophthalmopathy (1) · Multiple Myeloma (1) · Tissue Adhesions (1)
Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Endocrine System Diseases (8) · Diabetes Mellitus (7) · Glucose Metabolism Disorders (7) · Behavior (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Feeding Behavior (3) · Genetic Diseases, Inborn (3) · Dyslipidemias (2) · Hypoalphalipoproteinemias (2) · Hypolipoproteinemias (2) · Immune System Diseases (2) · Lipid Metabolism Disorders (2) · Lipid Metabolism, Inborn Errors (2)
Drug Evaluation (11) · Fluticasone (9) · Metformin (9) · Salmeterol Xinafoate (9) · Patents as Topic (6) · Sitagliptin Phosphate (6) · Tablets (6) · Ethinyl Estradiol (5) · Motion Pictures (4) · favipiravir (4) · Fluconazole (3) · Powders (3) · Rivastigmine (3) · dienogest (3) · Amlodipine (2)
Pharmtechnology LLC (16) · Laboratorios Andromaco S.A. (14) · Respirent Pharmaceuticals Co Ltd. (9) · Galenicum Health (6) · Darnitsa Pharmaceutical Company (5) · SocraTec R&D GmbH (5) · AstraZeneca (4) · Geropharm (4) · Pfizer (4) · Alembic Pharmaceuticals Ltd. (3) · Abbott (2) · Bayer (2) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Cinnagen (2) · Cycle Pharmaceuticals Ltd. (2)
Canada (14) · Russia (14) · United States (14) · China (10) · Chile (9) · Greece (9) · India (7) · Turkey (Türkiye) (7) · Germany (5) · Mexico (5) · Jordan (4) · Pakistan (4) · United Kingdom (4) · Egypt (3) · Iran (2)
Eric Sicard, MD (8) · Ioannis Stefanidis, Professor (8) · Muradiye Nacak, MD,PhD (6) · Taner Ezgi, MD (3) · Alexander Khokhlov (2) · Alexander Khokhlov, Professor (2) · Cornelius Koch, MD (2) · Eric Sicard (2) · Sergey Filatov (2) · Anastasia Teteryukova, MD (1) · Anna Chan (1) · Annelize Koch, Dr. (1) · Barbara Finck, MD (1)
PMID 36526947, PMID 10870982, PMID 17412566, PMID 17683253, PMID 18589125, PMID 19806435, PMID 20681586, PMID 21714845, PMID 21843564, PMID 22068541, PMID 23574401, PMID 24378755, PMID 26621118, PMID 31420787, PMID 31985294, PMID 35034311, PMID 35696054, PMID 37036155, PMID 39414078, PMID 41293254, PMID 42678488
2018 (2), 2008 (1), 2016 (1), 2023 (1)